Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Central Pacific Bank Trust Division

Central Pacific Bank Trust Division lessened its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 56.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,500 shares of the pharmacy operator’s stock after selling 4,500 shares during the period. Central Pacific Bank Trust Division’s holdings in Walgreens Boots Alliance were worth $33,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the company. State Street Corp lifted its holdings in shares of Walgreens Boots Alliance by 18.0% during the 3rd quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock worth $385,258,000 after acquiring an additional 6,569,223 shares during the period. Charles Schwab Investment Management Inc. increased its position in Walgreens Boots Alliance by 43.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock worth $98,284,000 after purchasing an additional 3,329,857 shares during the last quarter. Thompson Siegel & Walmsley LLC raised its stake in Walgreens Boots Alliance by 98.8% during the second quarter. Thompson Siegel & Walmsley LLC now owns 6,021,126 shares of the pharmacy operator’s stock worth $72,826,000 after purchasing an additional 2,992,648 shares during the period. Two Sigma Advisers LP acquired a new position in shares of Walgreens Boots Alliance in the 3rd quarter valued at $24,226,000. Finally, Newport Trust Company LLC purchased a new stake in shares of Walgreens Boots Alliance during the 2nd quarter valued at $31,028,000. Institutional investors and hedge funds own 58.59% of the company’s stock.

Analyst Upgrades and Downgrades

WBA has been the topic of several research reports. Royal Bank of Canada cut their target price on Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating on the stock in a research report on Wednesday, December 4th. Jefferies Financial Group reduced their price objective on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research note on Wednesday, October 23rd. Evercore ISI increased their target price on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a research report on Wednesday, October 16th. Morgan Stanley reduced their price target on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a research report on Friday, October 11th. Finally, Truist Financial dropped their price objective on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a research report on Monday, October 7th. Four research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, Walgreens Boots Alliance currently has an average rating of “Hold” and a consensus price target of $12.58.

Walgreens Boots Alliance Stock Performance

NASDAQ:WBA opened at $9.50 on Monday. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $25.87. The stock has a market cap of $8.20 billion, a P/E ratio of -0.95, a PEG ratio of 1.36 and a beta of 0.66. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37. The firm has a 50-day moving average of $9.21 and a two-hundred day moving average of $10.02.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The firm had revenue of $37.50 billion during the quarter, compared to analyst estimates of $35.75 billion. During the same quarter last year, the firm earned $0.67 EPS. Walgreens Boots Alliance’s quarterly revenue was up 5.9% on a year-over-year basis. On average, research analysts expect that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, December 12th. Shareholders of record on Monday, November 18th were issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 10.53%. The ex-dividend date of this dividend was Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio is currently -9.99%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.